These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11361694)

  • 1. Nevirapine expanded access program begins.
    AIDS Patient Care STDS; 1996 Apr; 10(2):131. PubMed ID: 11361694
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination trial with nevirapine underway.
    AIDS Patient Care STDS; 1996 Apr; 10(2):130-1. PubMed ID: 11361693
    [No Abstract]   [Full Text] [Related]  

  • 3. Viramune Expanded Access Program begins.
    AIDS Patient Care STDS; 1996 Jun; 10(3):186. PubMed ID: 11361629
    [No Abstract]   [Full Text] [Related]  

  • 4. New AIDS drugs.
    Minn Med; 1991 Dec; 74(12):46. PubMed ID: 1724284
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nevirapine--the first non-nucleoside inhibitor of reverse transcriptase in the battle against AIDS].
    Wiese E
    Pharm Unserer Zeit; 1997 Mar; 26(2):99-100. PubMed ID: 9289739
    [No Abstract]   [Full Text] [Related]  

  • 6. Nevirapine approved.
    AIDS Patient Care STDS; 1996 Dec; 10(6):378. PubMed ID: 11361568
    [No Abstract]   [Full Text] [Related]  

  • 7. Nevirapine expanded access.
    Posit Aware; 1996; 7(2):5. PubMed ID: 11363363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resisting the temptation.
    Lancet; 1993 Aug; 342(8869):448. PubMed ID: 7688842
    [No Abstract]   [Full Text] [Related]  

  • 9. Nevirapine and delavirdine plus protease inhibitors.
    GMHC Treat Issues; 1996 Apr; 10(4):8. PubMed ID: 11363709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-drug combos.
    Posit Aware; 1996; 7(1):6. PubMed ID: 11363125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Merck expanded access program August 11, 1995 deadline.
    Treat Rev; 1995; (no 19):3. PubMed ID: 11362754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonnucleoside reverse transcriptase inhibitor marketed for AIDS therapy.
    Am J Health Syst Pharm; 1996 Sep; 53(18):2132-3. PubMed ID: 8879315
    [No Abstract]   [Full Text] [Related]  

  • 13. [New treatments for HIV].
    Garcia E
    Sidahora; 1996; ():48-50. PubMed ID: 11363630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New HIV drugs cast in supporting roles.
    Voelker R
    JAMA; 1996 Aug; 276(8):585. PubMed ID: 8773618
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics, safety, and activity of nevirapine in human immunodeficiency virus type 1-infected children.
    Luzuriaga K; Bryson Y; McSherry G; Robinson J; Stechenberg B; Scott G; Lamson M; Cort S; Sullivan JL
    J Infect Dis; 1996 Oct; 174(4):713-21. PubMed ID: 8843207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New York ADAP to cover new AIDS drugs plus viral load testing.
    Link D
    GMHC Treat Issues; 1996 Sep; 10(9):12. PubMed ID: 11363840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nevirapine-plus-protease studies under way.
    AIDS Alert; 1996 Oct; 11(10):119. PubMed ID: 11363856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fewer brain lesions with AZT.
    Posit Aware; 1996; 7(1):7. PubMed ID: 11363133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nevirapine surprise.
    Smart T
    GMHC Treat Issues; 1996; 10(6/7):25. PubMed ID: 11363640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nevirapine approval expands combo possibilities--and HIV suppression.
    Vazquez E
    Posit Aware; 1996; 7(5):9. PubMed ID: 11363791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.